ストックスクリーナーアプリを入手
9.89
6.01%
0.57
前日終値:
$9.32
開ける：
$9.4
24時間の取引高:
670.78K
Relative Volume:
0.66
時価総額：
$779.03M
収益：
-
当期純損益:
-
株価収益率:
-
EPS:
-
ネットキャッシュフロー:
-
1週間 パフォーマンス:
+2.07%
1か月 パフォーマンス:
-30.52%
6か月 パフォーマンス:
+0.00%
1年 パフォーマンス:
+0.00%
1日の値動き範囲:
$9.39
$9.92
1週間の範囲:
$9.21
$9.92
52週間の値動き範囲:
$5.33
$14.69
Niagen Bioscience Inc Stock (NAGE) Company Profile
NAGE を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
NAGE
Niagen Bioscience Inc
|
9.89 | 734.13M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
467.85 | 120.60B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
565.34 | 60.80B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
329.29 | 42.87B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
597.23 | 36.23B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
297.63 | 31.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Niagen Bioscience Inc Stock (NAGE) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-05-27 | 開始されました | Canaccord Genuity | Buy |
| 2022-08-16 | ダウングレード | Oppenheimer | Outperform → Perform |
| 2022-08-11 | ダウングレード | B. Riley Securities | Buy → Neutral |
| 2022-03-08 | 開始されました | ROTH Capital | Buy |
| 2019-10-16 | 開始されました | Oppenheimer | Outperform |
| 2019-02-14 | 開始されました | B. Riley FBR | Buy |
| 2017-11-27 | 再開されました | H.C. Wainwright | Buy |
| 2017-09-25 | 開始されました | Ladenburg Thalmann | Buy |
| 2017-01-03 | 開始されました | Rodman & Renshaw | Buy |
すべてを表示
Niagen Bioscience Inc (NAGE) 最新ニュース
What is Niagen Bioscience Inc. company’s growth strategyAchieve rapid wealth accumulation through smart investing - jammulinksnews.com
Should I hold or sell Niagen Bioscience Inc. stock in 2025Invest confidently with professional guidance - jammulinksnews.com
How does Niagen Bioscience Inc. generate profit in a changing economyMaximize your investment portfolio’s performance - jammulinksnews.com
Why is Niagen Bioscience Inc. stock attracting strong analyst attentionFree High-Return Strategy Alerts - jammulinksnews.com
Niagen Bioscience Inc. Stock Analysis and ForecastHigh-yield capital appreciation - PrintWeekIndia
What drives Niagen Bioscience Inc. stock priceFree Market Volatility Navigation Tips - PrintWeekIndia
Does Niagen Bioscience Inc. stock pay reliable dividendsTriple-digit return opportunities - jammulinksnews.com
Is Niagen Bioscience Inc. a good long term investmentOutstanding growth strategies - Autocar Professional
Niagen Bioscience, Inc.'s (NASDAQ:NAGE) Stock Is Going Strong: Is the Market Following Fundamentals? - Yahoo Finance
Niagen Bioscience to Report Second Quarter 2025 Financial Result - GuruFocus
Niagen Bioscience to Report Second Quarter 2025 Financial Results on Wednesday, August 6, 2025 - Business Wire
Niagen Bioscience, Inc.'s (NASDAQ:NAGE) market cap dropped US$129m last week; individual investors who hold 33% were hit as were institutions - simplywall.st
What analysts say about Niagen Bioscience Inc. stockFree Consultation - Autocar Professional
Niagen Bioscience Shares Climb Following Exclusive License for Parkinson’s Therapy - MSN
Niagen Bioscience (NASDAQ:NAGE) Shares Down 4%Time to Sell? - MarketBeat
Niagen Bioscience, Inc. (NASDAQ:NAGE) Receives Average Rating of "Buy" from Brokerages - MarketBeat
Analysts Set Niagen Bioscience, Inc. (NASDAQ:NAGE) Target Price at $13.22 - Defense World
How Niagen Bioscience Inc. stock performs during market volatilityROI Driven Alerts - Newser
What makes Niagen Bioscience Inc. stock price move sharplyFree Stock Market Group - Newser
Why Niagen Bioscience Inc. stock attracts strong analyst attentionTop Growth Low Risk Stocks - Newser
Niagen Bioscience shares fall 1.15% intraday after announcing Tru Niagen debut at Equinox Hotel New York. - AInvest
Niagen Bioscience Inc (NAGE) 財務データ
Niagen Bioscience Inc (NAGE) の財務データはありません。詳細については、他の銘柄を確認してください。
収益
当期純利益
現金流量
EPS
Niagen Bioscience Inc (NAGE) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Lopez Carlos Luis | SVP, General Counsel |
Mar 07 '25 |
Buy |
7.86 |
273 |
2,146 |
2,251 |
| Jaksch Frank L Jr | Director |
Dec 13 '24 |
Option Exercise |
3.66 |
50,001 |
183,004 |
281,340 |
| Jaksch Frank L Jr | Director |
Dec 13 '24 |
Sale |
6.19 |
37,161 |
229,956 |
244,179 |
0.51%
0.49%
大文字化:
|
ボリューム (24 時間):